Tailored Therapy for Clarithromycin-Resistant H. Pylori
NCT ID: NCT03431688
Last Updated: 2025-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
782 participants
INTERVENTIONAL
2018-10-01
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Bismuth Containing Quadruple Therapy and Based Tailored Therapy for H. Pylori Infection
NCT03361267
H. Pylori Treatment Between Modified Quadruple Regimen and Tailored Therapy
NCT05002595
Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in Korea
NCT03665428
Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection
NCT02576236
Tailored H. Pylori Eradication Based on Clarithromycin Resistance
NCT03884348
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PAM
treatment with PPI, metonidazole, amoxicillin
PAM
treatment with PPI, metonidazole, amoxicillin
PBMT
treatment with PPI, metonidazole, bismuth, tetracyclin
PBMT
treatment with PPI, metonidazole, bismuth, tetracyclin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PAM
treatment with PPI, metonidazole, amoxicillin
PBMT
treatment with PPI, metonidazole, bismuth, tetracyclin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* H. pylori gastritis
* low grade MALT lymphoma
Exclusion Criteria
* severe comorbidity (ESRD, LC)
* hypersensitivity to drug
* pregnancy
19 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kangdong Sacred Heart Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shin, Woon Geon
Woon Geon Shin
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Woon Geon Shin
Role: PRINCIPAL_INVESTIGATOR
Kangdong Sacred Heart Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kangdong Sacred Heart Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KangdongSHH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.